AGENUS INC. news, videos and press releases - Page 3
For more news please use our advanced search feature.
AGENUS INC. - More news...
AGENUS INC. - More news...
- Investors Of Agenus Inc Can Join The Securities Fraud Investigation By The Schall Law Firm
- AGEN Investors Have Opportunity to Join Agenus Inc. Securities Fraud Investigation with the Schall Law Firm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agenus Inc. - AGEN
- Thinking about buying stock in Iovance Biotherapeutics, Agenus, Lucid Group, Bitdeer Technologies, or Jet.AI?
- Agenus To Host BOT/BAL Program Update at ESMO 2023
- Agenus Prioritizes Resources to Accelerate Registration and Commercialization of BOT/BAL Program in Multiple Cancers
- Agenus Reports Second Quarter 2023 Results
- Agenus Botensilimab/Balstilimab Data Update in Sarcomas Selected for Oral Presentation at ESMO 2023
- Agenus to Provide Second Quarter 2023 Financial Report and Corporate Update
- Agenus Expands Executive Leadership Team
- ESMO GI Data: Agenus' Botensilimab/Balstilimab Combination Achieves Unprecedented Survival in Advanced Colorectal Cancer
- Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO
- Agenus Announces Virtual Annual Shareholders Meeting
- Agenus to Participate in Jefferies Healthcare Conference
- Agenus Provides Corporate Update and First Quarter 2023 Financial Results
- Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI
- Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting
- Agenus to Provide Corporate Update and First Quarter 2023 Financial Report
- Agenus to Participate in May Investor Conferences
- Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer
- Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
- Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer
- Thinking about buying stock in Agenus, Lucira Health, Ford, SINTX Technologies, or Qualtrics International?
-
Agenus Inc. - AGEN Stock Chart Technical Analysis for 05-18-2021
- Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific Antibody Program
-
Agenus Inc. - AGEN Stock Chart Technical Analysis for 09-10-2020
- Paul Clark Joins Agenus Board of Directors
- Agenus Announces ESMO Oral Presentation of Two Clinical Trials of Balstilimab Alone and in Combination with Zalifrelimab in Recurrent or Metastatic Cervical Cancer
- Agenus Provides R&D Update & Second Quarter Financial Report
- Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference
